Psoriatic Arthritis
Psoriatic Arthritis (PsA) is a form of arthritis that affects some people with psoriasis, causing joint pain, stiffness, and swelling. It can lead to joint damage if not treated.
Psoriatic Arthritis: Zasocitinib Study
We are testing a new medication, Zasocitinib, for people with active psoriatic arthritis to see if it improves symptoms better than a placebo. The study also looks at how it affects daily life and physical function.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you 18 years old or older?
- Do you have a diagnosis of Psoriatic Arthritis (PsA)?
- Are you currently pregnant or breastfeeding?
- Are you taking any medications for PsA, such as corticosteroids (like prednisone), NSAIDs (like ibuprofen), or low-potency pain relievers (like tramadol)?
- Have you had any major surgery in the past 60 days?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Zasocitinib
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Centre Hospitalier Universitaire De Toulouse
Service de Rhumatologie
Blagnac, France
Ass Hospitaliere Protestante De Lyon
Caluire-et-Cuire, France
Centre Hospitalier Universitaire Reims
Service de Rhumatologie
Cormontreuil, France
Sponsor: Takeda Development Center Americas Inc.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.